Biopharm Business - BioPharm International


Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Life-Sciences IPOs Take a Breather

January 1, 2014

Frenzy cools as investors seeking a quick return turn elsewhere.

Nearly 400 Drugs in Development for Infectious Diseases

December 16, 2013

Almost 400 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections.

Employment Outlook: Mixed Results

December 1, 2013

The employment picture brightened a bit, but biopharma employees still seek better compensation.

Jobs Are Better in Biopharma, But There Is Room for Improvement

December 1, 2013

Higher wages and employment rates give biopharm professionals an edge over counterparts in other industries.

EC Approves Acquisition of Life Technologies by Thermo Fisher, With Conditions

November 26, 2013

Thermo Fisher must divest of cell culture media and sera lines, and other businesses, in purchase of Life Technologies.

Patheon to Merge with DSM Pharmaceutical Products

November 19, 2013

New CDMO to be formed from the combination of DSM Pharmaceutical Products and Patheon in a $2.6-billion transaction.

Robust IPO Market for Life Sciences Sparks Change Among Investors

October 1, 2013

Early-stage companies are now embraced by buyers of new issues.

Angiopoietins: Novel Targets for Anti-angiogenesis Therapy

October 1, 2013

The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.

Report from Myanmar

October 1, 2013

Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.



Click here